Marten Szibor
Martin Luther University of Halle-Wittenberg
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Marten Szibor.
Journal of Cell Biology | 2001
Joan B. Mannick; Christopher M. Schonhoff; Natalia Papeta; Pedram Ghafourifar; Marten Szibor; Kezhong Fang; Benjamin Gaston
Caspase-3 is a cysteine protease located in both the cytoplasm and mitochondrial intermembrane space that is a central effector of many apoptotic pathways. In resting cells, a subset of caspase-3 zymogens is S-nitrosylated at the active site cysteine, inhibiting enzyme activity. During Fas-induced apoptosis, caspases are denitrosylated, allowing the catalytic site to function. In the current studies, we sought to identify the subpopulation of caspases that is regulated by S-nitrosylation. We report that the majority of mitochondrial, but not cytoplasmic, caspase-3 zymogens contain this inhibitory modification. In addition, the majority of mitochondrial caspase-9 is S-nitrosylated. These studies suggest that S-nitrosylation plays an important role in regulating mitochondrial caspase function and that the S-nitrosylation state of a given protein depends on its subcellular localization.
The Journal of Physiology | 2000
Henning Morawietz; Roland Talanow; Marten Szibor; Uwe Rueckschloss; Andreas Schubert; Babett Bartling; Dorothea Darmer; Juergen Holtz
1 In this study, the effect of shear stress on the expression of genes of the human endothelin‐1 system was examined. Primary cultures of human umbilical vein endothelial cells (HUVEC) were exposed to laminar shear stress of 1, 15 or 30 dyn cm−2 (i.e. 0.1, 1.5 or 3 N m−2) (venous and two different arterial levels of shear stress) in a cone‐and‐plate viscometer. 2 Laminar shear stress transiently upregulates preproendothelin‐1 (ppET‐1) mRNA, reaching its maximum after 30 min (approx 1.7‐fold increase). In contrast, long‐term application of shear stress (24 h) causes downregulation of ppET‐1 mRNA in a dose‐dependent manner. 3 Arterial levels of shear stress result in downregulation of endothelin‐converting enzyme‐1 isoform ECE‐1a (predominating in HUVEC) to 36.2 ± 8.5%, and isoform ECE‐1b mRNA to 72.3 ± 1.9% of static control level. 4 The endothelin‐1 (ET‐1) release is downregulated by laminar shear stress in a dose‐dependent manner. 5 This downregulation of ppET‐1 mRNA and ET‐1 release is not affected by inhibition of protein kinase C (PKC), or tyrosine kinase. Inhibition of endothelial NO synthase (L‐NAME, 500 μm) prevents downregulation of ppET‐1 mRNA by shear stress. 6 In contrast, increasing degrees of long‐term shear stress upregulate endothelin receptor type B (ETB) mRNA by a NO‐ and PKC‐, but not tyrosine kinase‐dependent mechanism. 7 In conclusion, our data suggest the downregulation of human endothelin synthesis, and an upregulation of the ETB receptor by long‐term arterial laminar shear stress. These effects might contribute to the vasoprotective and anti‐arteriosclerotic potential of arterial laminar shear stress.
Antioxidants & Redox Signaling | 2001
Marten Szibor; Christoph Richter; Pedram Ghafourifar
Redox reactions and electron flow through the respiratory chain are the hallmarks of mitochondria. By supporting oxidative phosphorylation and metabolite transport, mitochondrial redox reactions are of central importance for cellular energy conversion. In the present review, we will discuss two other aspects of the mitochondrial redox state: (i) its control of mitochondrial Ca2+ homeostasis, and (ii) the intramitochondrial formation of reactive oxygen or nitrogen species that strongly influence electron flow of the respiratory chain.
Biochemical and Biophysical Research Communications | 2002
Henning Morawietz; Winfried Goettsch; Marten Szibor; Matthias Barton; Sidney Shaw; Kavous Hakim; Hans-Reinhard Zerkowski; Jürgen Holtz
In this study, we investigated the role of the renin-angiotensin system in expression of the endothelin system in atrial myocardium of patients with congestive heart failure. Atrial myocardium of control patients without angiotensin-converting enzyme (ACE) inhibitor therapy and heart failure patients without or with ACE inhibitor therapy undergoing aorto-coronary bypass surgery was studied. Endothelin-converting enzyme-1 (ECE-1) expression and endothelin-1 peptide level was upregulated in myocardium of heart failure patients without ACE inhibition. ACE inhibitor therapy prevented upregulation of ECE-1 and endothelin-1 in failing myocardium. Prepro-endothelin-1 and endothelin receptor A expression were not affected by heart failure. Endothelin receptor B was downregulated in heart failure patients. Our data demonstrate an upregulation of ECE-1 mRNA expression in failing human myocardium. Inhibition of the renin-angiotensin system by ACE inhibitor treatment prevents upregulation of ECE-1, suggesting that angiotensin II regulates ECE-1 expression in vivo.
Clinical Science | 2002
Henning Morawietz; Winfried Goettsch; Marten Szibor; Matthias Barton; Sidney Shaw; Kavous Hakim; Hans-Reinhard Zerkowski; Juergen Holtz
Endothelin-1 (ET-1) is considered to be involved in the development and progression of heart failure. Therefore, we analysed the expression of endothelin-converting enzyme-1 (ECE-1), endothelin receptors A (ET(A)) and B (ET(B)) mRNAs by standard-calibrated, competitive reverse transcriptase-PCR using an internal-deleted in vitro-transcribed cRNA standard. ET-1 peptide levels were measured using isoform-specific rabbit antibodies against synthetic ET-1. mRNA and protein expression was determined in the right atrial myocardium of New York Heart Association class I patients and class IV patients undergoing aorto-coronary bypass surgery. ECE-1 mRNA was upregulated in failing atrial myocardium. Furthermore, ET-1 peptide levels were increased in failing atrial myocardium. Atrial ET(A) mRNA expression was not changed, while ET(B) mRNA was downregulated in the failing atrial myocardium. Our results support an upregulation of ET-1 synthesis by induction of ECE-1 in failing atrial myocardium. Pharmacological inhibition of augmented ECE-1 expression might provide a new therapeutic perspective in the treatment of heart failure.
Technical Tips Online | 2001
Marten Szibor; Henning Morawietz
The polymerase chain reaction (PCR) was first described in 1985 (Ref. [1] ). Since then, it has become the ‘gold standard’ for amplifying DNA and reverse-transcribed RNA. Unfortunately, the greatest advantage of PCR (its sensitivity) easily becomes its biggest disadvantage, as the smallest changes in reaction conditions from tube to tube result in large differences in the outcome. During the past few years, there has been increasing interest in semiquantitative and quantitative PCR (Ref. [2] ). Several protocols for how to generate and use internally deleted standards have been published (Ref. 3 , 4 , 5 ). The aim of this study was to measure gene expression using the high specificity and sensitivity of competitive PCR techniques but at a lower cost.
Biochemical and Biophysical Research Communications | 2001
Winfried Goettsch; Thomas Lattmann; Kerstin Amann; Marten Szibor; Henning Morawietz; Klaus Münter; Sylvana P. Müller; Sidney Shaw; Matthias Barton
Circulation | 2000
Henning Morawietz; Marten Szibor; Winfried Goettsch; Babett Bartling; Matthias Barton; Sidney Shaw; Reiner Koerfer; Hans-Reinhard Zerkowski; Juergen Holtz
Biochimica et Biophysica Acta | 2006
Heiko Noack; Tobias Bednarek; Juliana Heidler; Roman Ladig; Jürgen Holtz; Marten Szibor
BioTechniques | 2002
Marten Szibor; Henning Morawietz